Jefferies Financial Group Inc.

Position in OLMA — Olema Pharmaceuticals, Inc.

CIK 96223 NEW YORK, NY

Back to OLMA Full portfolio

Position in OLMA

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$137,610

+$33,240 QoQ

Shares Held

11,000

+57.1% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#132

of 182 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in OLMA Over Time

Shares Held

Position Value (USD)

Derivatives in OLMA

reported options exposure · as of Jun 30, 2026

CallValue

CallShares

PutValue

$187,650

PutShares

15,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names. OLMA ranks #58 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PTCT	Ptc Therapeutics, Inc.	1,357,042	$110,693,915
2	URGN	UroGen Pharma Ltd.	2,199,652	$80,947,193
3	IMTX	Immatics N.V.	6,506,802	$65,913,904
4	TNGX	Tango Therapeutics, Inc.	2,010,534	$62,849,292
5	CGON	CG Oncology, Inc.	769,947	$54,704,734
6	ARGX	Argenx SE	45,068	$41,812,738
7	RARE	Ultragenyx Pharmaceutical Inc.	929,626	$31,040,212
8	BMRN	Biomarin Pharmaceutical Inc	466,258	$26,679,282

All Filings in OLMA

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$187,650	15,000	0.0%	Put	Defined	2026-08-17
2026-06-30	$137,610	11,000	+57.1%	Shares	Defined	2026-08-17
2026-03-31	$104,370	7,000	+133.3%	Shares	Defined	2026-05-08
2026-03-31	$223,650	15,000	0.0%	Put	Defined	2026-05-08
2025-12-31	$375,000	15,000	—	Put	Defined	2026-02-09
2025-12-31	$75,000	3,000	—	Shares	Defined	2026-02-09
No filing history on record for this holder in this stock.